Back

Predictors of implantable cardioverter-defibrillator therapies: a 6-year follow-up study

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in arrhythmias and device therapy 5 Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Diogo De Almeida Fernandes

Coimbra Hospital and University Center, Coimbra (Portugal)

6 More presentations in this session

Presentation thumbnail
Implantable cardioverter-defibrillators in the elderly
Doctor S. Cha (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Non-ischemic cardiomyopathy patient's survival results of the intracardiac device implanted versus medical therapy
Doctor M. Kose (Izmir, TR)
Abstract Slides Video
Presentation thumbnail
Quality of life and psychological well-being among heart failure patients living with an implantable cardioverter-defibrillator
Doctor B. Dobai (Targu Mures, RO)
Abstract Slides Video
Presentation thumbnail
Subcutaneous implantable cardioverter defibrillator: a real world 9 years experience of a portuguese centre
Doctor H. Santos Moreira (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: real world data from a Portuguese cohort
Doctor H. Santos Moreira (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in arrhythmias and device therapy 5

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Risk factors for first and recurrent ICD therapy in primary and secondary prevention patients with an implantable cardioverter defibrillator
thumbnail
Congress Presentation
Sex differences in the incidence of appropriate ventricular arrhythmias therapy in patients with ICD or CRT-D for primary prevention
thumbnail
Congress Presentation
Clinical outcomes of implantable cardioverter defibrillators in heart failure: a comparative analysis between ischemic and non-ischemic cardiomyopathy patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources